News & Updates
Filter by Specialty:
Disease-modifying agents for multiple sclerosis do not elevate cancer risk
09 Jan 2022
Several disease-modifying therapies (DMTs) for multiple sclerosis (MS) do not pose an increased risk of cancer, a study has shown.
Disease-modifying agents for multiple sclerosis do not elevate cancer risk
09 Jan 2022Prior stroke may influence ischaemic stroke risk in cancer patients
07 Jan 2022
byRoshini Claire Anthony
Prior history of ischaemic stroke appears to affect the risk of ischaemic stroke in patients newly diagnosed with cancer, according to a study from Canada presented at ASH 2021.
Prior stroke may influence ischaemic stroke risk in cancer patients
07 Jan 2022CNS complications in COVID-19: 1 in 100 hospitalized patients affected
27 Dec 2021
byRoshini Claire Anthony
A large retrospective study conducted in the US and Europe and presented at RSNA 2021 has suggested that central nervous system (CNS) complications may affect approximately one in 100 patients hospitalized with COVID-19.